Association of HLA-DPB1 ∗0501 with early-onset graves' disease in Japanese
References (61)
- et al.
A simple and rapid method for HLA-DP genotyping by digestion of PCR-amplified DNA with allele-specific restriction endonucleases
Hum Immunol
(1990) Autoimmune diseases: Overview and current concepts of pathogenesis
Clin Biochem
(1992)- et al.
MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness
Adv Immunol
(1979) - et al.
The class II molecules of the human and murine major histocompatibility complex
Cell
(1984) - et al.
A molecular basis for genetic susceptibility to insulin-dependent diabetes mellitus
Trends Genet
(1988) - et al.
HLA-A and DPB1 loci confer susceptibility to Graves' disease
Hum Immunol
(1992) - et al.
HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease
J Clin Endocrinol Metab
(1974) - et al.
The association of HLA with autoimmune thyroid disease in Newfoundland: the influence of HLA homozygosity in Graves' disease
Tissue Antigens
(1976) - et al.
HLA antigens in Graves' disease
Acta Endocrinol
(1977) - et al.
A study of human leukocyte D locus related antigens in Graves' disease
J Clin Invest
(1979)
HLA and Graves' disease: an association with HLA-DRw3
J Clin Endocrinol Metab
Graves' disease and HLA: clinical and epidemiologic associations
Clin Endocrinol
Association of HLA antigens with thyrotoxic Graves' disease and periodic paralysis in Hong Kong Chinese
Clin Endocrinol
HLA Bw46 and DR9 associations in Graves' disease of Chinese patients are age- and sex-related
Tissue Antigens
HL-A antigens in Japanese patients with Graves' disease
Tissue Antigens
HLA-BW35 and B5 in Japanese patients with Graves' disease
Acta Endocrinol
Japanese Graves' disease: association with HLA-Bw46
Endocrinol Jpn
The effects of HLA class II genes on the susceptibility to the autoimmune thyroid diseases [in Japanese, with English abstract]
Fukuoka Acta Med
Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease
Nature
Microdroplet assay of human serum cytotoxins
Nature
1970 microdroplet lymphocyte cytotoxicity test
Microdroplet testing for HLA-A, -B, -C, and -D antigens
Am J Clin Pathol
Human T lymphocyte clones reactive in primed lymphocyte typing and cytotoxicity
Nature
Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogeneic proliferative and cytotoxic responses
J Exp Med
Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia
Science
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase
Science
Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus
Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes
HLA-DQB1 genotyping by a modified PCR-RFLP method combined with group-specific primers
Tissue Antigens
Modified PCR-RFLP method for HLA-DPB1 and -DQA1 genotyping
Tissue Antigens
Cited by (51)
Neuromyelitis optica spectrum disorders
2021, Journal of the Neurological SciencesCitation Excerpt :Aquaporin-4 IgG positivity is found to be associated with HLA-DRB1*03 (DR3) in French and Brazilian populations and HLA-DPB1*0501 in Japanese and Chinese populations [18]. These HLA haplotypes are also associated with other autoimmune disorders such as systemic lupus erythematosus (SLE) and Graves' disease [19]. Autoimmune conditions such as SLE, Myasthenia Gravis and Sjogren's syndrome are found in association with NMO [23] and these disorders are also more common in family members of patients with NMO [17].
Future Directions of Genomics Research in Rheumatic Diseases
2017, Rheumatic Disease Clinics of North AmericaCitation Excerpt :Although this region is only 0.1% of the length of the human genome, the MHC region confers most of the risk for most rheumatic diseases. The initial identification of the genetic risk loci was reported to be associated with the HLA genes located in the MHC region, such as HLA-DRB1 for RA,5 HLA-C for psoriasis,6 HLA-B for ankylosing spondylitis,7 and HLA-DPB1 for Graves disease.6 However, delineation of the detailed disease risk of HLA alleles has been challenging and controversial owing to the complex structures of the polymorphisms in the MHC region.
Ethnic differences in the clinical presentation of Graves' ophthalmopathy
2012, Best Practice and Research: Clinical Endocrinology and MetabolismCitation Excerpt :A meta-analysis of these three alleles by Bednarczuk et al estimated that the combined OR for HLA-DRB1*03, DRB1*04 and DRB1*07 as risk factors for GO were 1.5 (95% confidence intervals 0.9–2.5), 0.9 (CI 0.6–1.6) and 0.8 (0.5–1.1) respectively, although none of them showed statistically significant association (P > 0.05).38 In Asian populations, the association of HLA with GD is less clear from the small studies done in Japanese, Korean and Chinese patients.39–45 The most prominent susceptibility allele in Caucasians, DRB1*03:01, has a much lower frequency in Asians, ranging from less than 3% in Japanese and Koreans to 4–9% in Chinese,46,47 and HLA-B*46 might be the only HLA allele associated with GD with good replications in Asians.44,48
Neoself Antigens Presented on MHC Class II Molecules in Autoimmune Diseases
2024, Advances in Experimental Medicine and Biology